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EFFECTS OF EMU OIL ON DELAYED ONSET MUSCLE SORENESS
OF THE QUADRICEPS
Michaelyn Sebold, M.A.
Western Michigan University, 2004
Limited research on emu oil has shown evidence of anti-inflammatory
activity. Currently, emu oil has been used anecdotally to reduce soreness after
physical activity. The purpose of the study was to examine the effects of emu oil on
delayed onset muscle soreness in the quadriceps. The objectives were to examine
whether emu oil decreased soreness perceptually and physiologically after eccentric
exercises on a leg extension machine.
The research design was a double blind format. Subjects were randomly
assigned to three groups. Those three groups were randomly assigned to a given
treatment order (control, placebo, or treatment). This was a counter-balanced study,
allowing for subjects to serve as their own control. A repeated measures analysis of
variance (RM ANOVA) was performed to analyze the data.
Results showed no significant effect on creatine kinase levels but did decrease
muscle soreness. Significance was found perceptually through the visual analog scale
at 36-hours post-exercise in the emu oil condition.
In conclusion, there was a subjective decrease in soreness with regard to the
emu oil treatment but that may not have been related to decreased muscle damage.
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INTRODUCTION
Delayed onset muscle soreness (DOMS) is a common phenomenon that is
experienced by many individuals following physical activity. It is often described as a
sensation ofmuscular discomfort and pain during active contractions that occur in a
delayed fashion after strenuous exercise. The severity ofDOMS can range from a dull
ache to unbearable pain (3,15). Symptoms such as muscle stiffness, point tenderness,
and aching usually develop in the first 24 hours and disappear within five to seven
days (11).
There are two basic mechanisms to explain how exercise initiates muscle
damage (17). Mechanical and metabolic mechanisms seem to initiate a sequence of
inflammatory and immunological events that lead to muscle fiber damage.
Mechanical stress has been proposed to account for the damage, specifically
mechanical shear forces that are produced during exercise. Mechanical stress derives
from the activity the muscle performs. Eccentric activity has shown to initiate the
most intense effects from DOMS (9, 16,19). The mechanical shear forces produced
during eccentric contractions can cause disruption in skeletal muscle and connective
tissue leading to an inflammatory response. Metabolic stress focuses on the role of
disturbances in normal cellular metabolism as the result ofexhaustive endurance
exercise. Insufficient rates ofmitochondrial adenosine triphosphate, ischemia,
hypoxia, and general waste accumulation are metabolic stressors that may account for
DOMS.
The increased concentration ofproteins in plasma after exercise is one method
to determine muscle damage. Proteins that are often abundant following exercise are:
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(1) lactate dehydrogenase, (2) aspartate aminotransferase, (3) myoglobin, (4)
troponin, and (5) creatine kinase (CK). For the purposes of this study, CK was the
chosen marker due to the frequency of its use in other research to indicate DOMS.
The increased presence of this protein reflects skeletal muscle damage and a change
in tissue structure. Elevations in CK begin around 24 hours post-exercise and peak
between 48 and 72 hours (10,11).
Many methods have been used to decrease the symptoms ofDOMS. Non
steroidal anti-inflammatories (1,9), passive stretching (13), counterirritant creams (6),
and fish oil (10) have all been used to minimize the effects ofDOMS after exercise.
Results of these studies indicate no effective method in the treatment ofDOMS
symptoms. Another method being researched in the treatment ofDOMS is emu oil.
Emu oil is a natural substance extracted from the fatty tissue of the emu bird. The oil
naturally contains a high level of linolenic acid (a substance that may ease muscle
aches and joint pain) (20) and oleic acid, which provides a local anti-inflammatory
effect (18).
In humans, research studies indicate that patients suffering from arthritis who
applied emu oil significantly relieved their pain, morning stiffness, and swelling (8).
Most research involving emu oil has been conducted predominantly on mice or rats to
determine its effect on limiting inflammation (12).
Current research is limited in regards to therapeutic effects of emu oil to
decrease DOMS. Most reports of the effects of emu oil are anecdotal. The purpose of
this study was to determine if topical emu oil could decrease delayed onset muscle
soreness of the quadriceps muscle after an eccentric leg extension exercise bout.
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METHODS AND PROCEDURES
Subjects
Six men (ages: 22.8 ± 3.8 years; weight: 87.8 ± 21.6 kg) and 6 women (ages:
22.2 ± 1.8 years; weight: 69.3 ± 13 kg) volunteered to participate in this study.
Subjects were non-competitive athletes living non-sedentary lifestyles. Exclusion
criteria for participants included: (1) taking non-steroidal anti-inflammatory
medication, (2) participation in unaccustomed physical activity ten or more hours per
week, (3) participation in competitive sports, (4) known bleeding disorders, (5)
bruising, swelling, or infection to the right quadriceps muscle, and (6) over 40 years
of age. All 12 subjects were fully informed of the purpose of this study and the nature
of the potential risks associated with the procedures. All subjects read and signed an
informed consent document approved by the Western Michigan University Human
Subjects Institutional Review Board.
Procedures
The study was divided into three conditions, each lasting three days per week,
and separated by a washout period of one week in order to allow the subjects to
recover. Prior to the first session, subjects came to the Exercise Physiology
Laboratory at Western Michigan University (WMU) in order to perform an eccentric
one repetition maximum (lRM) test on the leg extension machine. The lRM was
used as the starting weight for all three trials. After determining the lRM, subjects
were randomly assigned to one of three trials: (1) DOMS protocol followed by the
application of emu oil, (2) DOMS protocol followed by the application of a placebo,
or (3) DOMS protocol and no topical application. This was a counter-balanced study
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where randomization of the conditions was conducted throughout the entire study and
all subjects completed each of the three conditions.
Subjects were asked to refrain from unaccustomed physical activity 24 hours
prior to participating in each trial session. On the first day of each trial, subjects went
to Sindecuse Health Center on the WMU campus to have a baseline blood draw. Each
draw was a venipuncture procedure with 8mL of blood taken from the ante-cubital
region on the right or left arm. Blood samples were then sent to Borgess Medical
Center for analysis. The baseline blood draw was necessary in order to determine
each subject's creatine kinase levels prior to exercising. Following the completion of
the baseline blood draw, subjects returned to the Exercise Physiology Laboratory to
perform the eccentric DOMS exercise protocol.
Eccentric exercises performed on a leg extension machine were used to induce
DOMS. The investigator lifted the weight, and beginning at full extension, the subject
lowered the weight slowly at a four second count until the knee was flexed at a 90
degree angle. The subjects started at their lRM and when they could not perform the
eccentric exercise in a controlled manner, the weight was decreased in 15-pound
increments. The procedure continued until the subject could no longer support 15
pounds of weight. This protocol followed recommendations from a study conducted
by Lecomte et al. Use of this protocol required 7 to 10 sets and 6 to 15 repetitions per
set in order to reach the endpoint of 15 pounds.
The research design was double blind. A Western Michigan University faculty
member not associated with the study assisted in maintaining the double blind.
Subjects, unaware of the exact treatment, administered emu oil, placebo, or no oil to

4

the right quadriceps muscle following the DOMS protocol. Approximately lmL or
fifteen drops of either emu oil or placebo was placed on the length of the quadriceps.
Subjects manually administered the topical for 60 seconds at their own rate.
After completion of the DOMS exercises and oil application, subjects returned
to Sindecuse Health Center to have two more blood samples collected, one at 24
hours and one at 48 hours post DOMS protocol. Each subject then evaluated his or
her perceived level of soreness using a 10-point visual analog scale with O = no
soreness and 10 = extreme soreness. Subjects circled the number on the scale that best
indicated their level of perceived soreness. Perceived soreness was evaluated at 8, 12,
24, 36, and 72 hours post-exercise in all three conditions.
Statistical Analysis
A 3 x 3 (treatment x time) RM ANOVA was used to examine the difference
among the creatine kinase levels (a = .05). A 3 x 5 (treatment x time) RM ANOVA
was used to assess perceived soreness. A post hoc tukey test was conducted in order
to determine statistical significance. Data analysis was performed using the Statistical
Package for the Social Sciences (SPSS, Chicago, IL) version 11.0.
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RESULTS
There were no significant differences found with time or treatment of the CK
levels. Creatine kinase levels remained relatively unchanged with the exception of the
control condition at the 48 hour blood draw.
Significance was found within the conditions over time for perceived pain (F
(1,11) = 8.19, p = .015) (Table 2). Specifically, the perceived pain at the 36 hour
mark was significantly lower for the emu oil condition compared to the control and
placebo conditions. Trend analysis determined all treatments showed a significant
quadratic trend meaning that soreness slightly increased over time but decreased at
the 72 hour mark. Only the placebo treatment showed a significant cubic trend as well
meaning that soreness increased and decreased on more than one occasion during this
condition.
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DISCUSSION
Numerous methods have been used to effectively induce DOMS such as
isokinetic dynamometers (3,13,14), downhill running (1,19), and stepping (4). The
eccentric exercise parameters chosen for this study were also effective in inducing
DOMS. Muscle soreness was created in the quadriceps muscle through eccentric leg
extension exercises in all subjects for each trial. Subjects experienced pain as early as
8-hours post-exercise, but all reported that the quadriceps were not painful after 72hours post-exercise. Subjects experienced their peak amount of soreness between the
24 and 36 hour mark and decreased at 72 hours post-exercise which is consistent with
other studies inducing DOMS (13, 14, 19).
CK levels were chosen as an indication ofDOMS because it is a frequently
used indicator of muscle damage. No significant changes in CK levels were found in
our study. This could be attributed to a high rate of variability between CK levels,
with some subjects experiencing very high levels of change in CK, while others
remained relatively unchanged. For example the baseline mean CK level for the
placebo treatment was 499.5 (IU/L) with a standard deviation of 812.9 (IU/L) (Table
1). Variability in CK levels is consistent with other studies (3,10,19). Lenn et al.
found CK levels to range from extremely high (27,450 U/L- 1 and 12,645 U/L- 1) to
relatively unchanged (62-81 U/L-1). Franklin et al. found a 15,315% elevation in CK
levels from the baseline recordings in their research. The CK levels found by
Schwane et al. indicated a 351% increase at 24 hours post-exercise and even a 141%
increase at the 48 hour mark.
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Due to extreme variability, CK may not have been the best physiological
indicator for this study. The presence of CK can be indicative of increased
permeability or breakdown of the muscle cell membranes that can occur anywhere in
the body, not just the quadriceps muscle. CK reflects not only skeletal muscle damage
but also brain, lung, and heart damage. CK delivers a generalized indication of
muscle damage within the body whereas another marker such as troponin would
specifically indicate damage to skeletal muscle because it is directly associated with
that tissue type. CK levels also vary according to a person's muscle mass so
individuals with larger musculature may generally have normal high ranging levels
(7).
CK variability may have been decreased in a few ways in this study. Subjects
could have been trained individuals who were involved in accustomed physical
activity as opposed to unaccustomed. Research conducted on trained versus untrained
individuals found that CK levels were decreased in those who were trained in the
eccentric activity (11). Training either prevents or minimizes the severity of muscle
injury that occurs following eccentric exercises which means with less muscle
damage there is a decrease in protein breakdown. Another study conducted by Evans
et al. involving trained versus untrained individuals found that athletes had
chronically elevated CK levels but had no consistent change upon completion of the
study (2).
Another attempt at decreasing CK variability should include having subjects
refrain from unaccustomed physical activity for a longer period of time. Since the
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effects ofDOMS lasts between 24 and 72 hours, subjects may have participated in
strenuous activity up until 24-hours prior to participation.
Other muscle damage markers could have been used for this study that may
have given a better physiological indication as to whether the emu oil had any effect.
One such marker could have been troponin. Troponin is a regulatory protein found in
striated muscles that regulates the force and velocity ofa muscle contraction and can
be used to indicate skeletal muscle damage. After muscle injury, there is an increase
in plasma levels ofskeletal troponin which can remain elevated for up to two days
(7). However, the use oftroponin as an inflammation marker is not as widely used as
the CK marker due to the sensitivity in measuring the low values within the blood and
because ofit being a rather new form oftechnology in regards to measuring muscle
soreness (7).
It may be possible that the amount ofemu oil applied was insufficient due to
the large musculature ofthe quadriceps. The amount ofemu oil, lmL, may not have
been enough to penetrate far enough beyond the skin and adipose tissue in order to
have an effect on the muscle. Repeated applications may have been necessary in order
to effectively penetrate tissues surrounding the quadriceps. Penetration ofthe oil may
have also been inhibited by manual application. More oil could have remained on the
hands ofsubjects rather than penetrating into the quadriceps.
A supplementation process may have been more beneficial. Emu oil samples
could have been given to the subjects to apply throughout the course ofthe study.
Subjects could have started application ofthe emu oil prior to exercising and
continued that application on a daily basis.
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Significance was found in the visual analog scales 01AS) at 36 hours post
exercise for the emu oil condition. Subjects perceived less pain at the 36-hour marker
after application of the emu oil. This may have been the time at which subjects started
to feel diminished pain sensations in the quadriceps.
The reason for the decreased soreness during the emu oil condition is
unknown. Physiologically, the emu oil did not change the damage that occurred to the
quadriceps which was evident in the unchanged CK levels however, soreness was
perceived as less severe during the emu oil condition. The decrease in soreness is
possibly associated with a decrease in pain receptor sensitivity but that does not mean
the damage that resulted from exercising completely resolved itself. The expectation
of finding a decrease in perceived pain was met by findings from the study however
the results of our two objectives cannot support the hypothesis that emu oil would
have an effect on delayed onset muscle soreness.
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CONCLUSION
In summary, this double-blind, randomized study demonstrated the following:
1. After eccentric exercise designed to produceDOMS, CK levels indicated
no significant change in all three conditions (placebo, emu oil, and
control).
2. After the development of muscle soreness� only at the 36-hour post
exercise mark of the emu oil condition (indicated by VAS scores) was
there a significant decrease in perceived soreness by subjects.
3. Emu oil was ineffective at decreasing the CK levels produced following
exercise however, it was effective in reducing perceived soreness. This
may indicate that even though its use for this particular study was
ineffective it may be useful in future research involving muscle soreness.
Further research involving emu oil needs to be conducted in order to
determine its efficacy as a possible treatment for delayed onset muscle soreness.
Future studies could involve physically trained individuals to reduce the variability in
muscle damage markers. The amount and supplementation of emu oil could also be
manipulated for further studies in order to determine if it could be used as a treatment
forDOMS.
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Table 1. Values for Creatine Kinase Levels for Conditions over Time
Baseline

24hr

48hr

Control

187.9± 342.6

181.7± 236.8

160.0± 111.8

Emu Oil

138.8± 94.1

131.8± 40.9

252.3± 496.1

Placebo

86.2± 26.1

145.8± 116.9

499.5± 812.9
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Table 2. Perceived Pain Means Following Control, Placebo, and Emu Oil Conditions
Control
M±SD

Emu
M±SD

Placebo
M±SD

8 hours

2.16±.55

1.41±.40

1.91±.58

12 hours

3.50±.70

2.00±.58

2.91±.57

24 hours

4.41±.60

3.33±.51

3.91±.54

36 hours

4.83±.44

3.75±.57*

5.00±.76

72 hours

2.75±.58

3.16±.75

3.33±.78

Time

w

Muscle soreness was assessed using a 10-point visual analog scale,
0 being no soreness and 10 being extremely sore.
*Indicates Significance over time among all three conditions

Appendix A
Research Protocol Approval
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WESTERN MICHIGAN UNIVERSllY
Human Subjects Institutional Review Board

Date: August 5, 2003
To:

Michael Miller, Principal Investigator
Michaelyn Sebold, Student Investigator for Thesis

From: Mary Lagerwey, Ph.D., Chair
Re:

(VI/ ,;;} �

HSIRB Project Number 03-06-18

This letter will serve as confirmation that your research project entitled "Effects of EMU
Oil on Delayed Onset Muscle Soreness of the Quadriceps Muscle" has been approved
under the full category of review by the Human Subjects Institutional Review Board. The
conditions and duration of this approval are specified in the Policies of Western Michigan
University. You may now begin to implement the research as described in the
application.
Please note that you may only conduct this research exactly in the form it was approved.
You must seek specific board approval for any changes in this project. You must also
seek reapproval if the project extends beyond the termination date noted below. In
addition if there are any unanticipated adverse reactions or unanticipated events
associated with the conduct of this research, you should immediately suspend the project
and contact the Chair of the HSIRB for consultation.
The Board wishes you success in the pursuit of your research goals.
Approval Termination:

July 16, 2004
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Walwood Hall, Kalamazoo, Ml 49008-5456
PHONE (269) 387-8293 FAX: (269) 387-8276

Appendix B
Informed Consent Document
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Western Michigan University
Department of Health, Physical Education, and Recreation
1. STUDY TITLE:

Effects of Emu Oil on Delayed Onset Muscle Soreness
of the Quadriceps Muscle.

2. INVESTIGATOR (S}:

Michael G. Miller, EdD, ATC, CSCS
Michaelyn Sebold, ATC

3. SUBJECTS:

Twelve undergraduate/graduate students or faculty
volunteers from Western Michigan University.

4. PURPOSE OF THIS STUDY:

The purpose of this study is to examine the
effects of emu oil on delayed onset muscle
soreness (DOMS) in the quadriceps muscle.

5. WHAT YOU WILL BE ASKED TO DO IF YOU PARTICIPATE IN TIDS
STUDY:
You will be asked to attend three sessions (approximately 1 hour each) with
Michaelyn in the exercise physiology lab in the Student Recreation Center at Western
Michigan University. This study should last no longer than 5 weeks. You will also be
asked to go to Sindecuse Health Center for a total of 9 blood draws consisting of
8mLs of blood with each draw (approximately 2 teaspoons) throughout the course of
this study. Blood will be taken from the arm at the bend in the elbow. Mr. Brien
Leonard from Sindecuse will be performing the draws in the examination rooms. The
student investigator will meet you for the first blood draw in order to familiarize you
with Sindecuse Health Center. You will be asked to refrain from any unaccustomed,
physical activity 24 hours prior to each session. The student investigator will call you
48 hours prior to participation to remind you about refraining from activity and to
attend the baseline blood draw appointment.
Then you will be asked to go through the following list of events after the baseline
blood draw:
a.
You will be asked to meet in the exercise lab at Western Michigan
University to perform a one repetition maximum test (IRM) on the right thigh
during the orientation session. This test is performed on a leg extension
machine. You will be asked to slowly flex your knee from an extended
position with the largest amount of weight that you can tolerate. This
determines the start weight for the test.
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b.

You will then be randomly assigned to one of three trials:
1) Soreness protocol and emu oil application
2) Soreness protocol and placebo application
3) Only the soreness protocol
This random assigning will also be used for the second session. The third
session will be the trial you have not already participated in. By the end of the
study, you will have participated in all three trials.
c.
You will then go to Sindecuse Health Center to have a baseline blood
draw. Upon completion of that first draw you will be asked to return to the
exercise lab in the Student Recreation Center to perform the soreness protocol.
This is done in order to fatigue the right thigh muscle. The lRM weight will
be used as the starting weight. You will slowly flex your knee from an
extended position for each repetition. As you fatigue, the weight is lowered
until you can no longer support 15 pounds. Each repetition will last 4 seconds.
d.
Fifteen drops of either emu oil or placebo will be placed on the entire
length of the right thigh. You will be asked to rub the substance in for one
minute.
e.
You will then be asked to return to Sindecuse for two of the three
blood draws. The second draw is 24 hours after exercise and the third is 48
hours after exercise. The student investigator will call you 2 hours prior to
these times in order to remind you about these draws.
f.
You will be given a packet to take home after each of the three
sessions. This packet contains 5 sheets of paper which contain soreness scales.
There are 5 hours post-exercise where you will be asked to record your level
of soreness (hours: 8, 12, 24, 36, 72).
g.
You will be asked NOT to refer back to previous recordings when
filling out each scale. Please bring your packet to the next trial session. The
student investigator will collect the third packet at the final blood draw at
Sindecuse.
You will be asked NOT to do or take anything that will relieve your discomfort in the
thigh for the first 48 hours following exercise. You will be given TWO WEEKS
between each session in order for your thigh to recover. The same steps will be
followed for each session.
6. POSSIBLE RISKS OF YOUR PARTICIPATION IN TIDS STUDY:
There are possible foreseeable discomforts if you participate in this study.
Foreseeable discomforts include soreness and weakness to the right quadriceps
muscle. Delayed onset muscle soreness usually appears approximately 24 hours after
exercise. It lasts between 5 and 7 days. There may also be possible discomfort from
the blood draws. Bleeding, bruising, or swelling may occur at the site of the draw. As
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in all research, there may be unforeseen risks to the participant. If an accidental injury
occurs, appropriate emergency measures will be taken; however, no compensation or
additional treatment will be made available to you except as otherwise stated in this
consent form.
There are no benefits to participants in this study. You will NOT be compensated for
participating in this study.
7. OTHER:
Creatine kinase (CK) is the chosen soreness marker for this study. The blood draws
determine the levels of CK in your blood stream. CK is the ONLY element that will
be analyzed in this study.
In order to maintain confidentiality the study will be focused on group data and an
identification number (rather than the subject's name) will be used to record data.
Following the study, the primary investigator and the research committee will have
access to the original data. The original data will be retained in a locked cabinet for a
minimum of three years after the completion of the study in the department of Health,
Physical Education, and Recreation at Western Michigan University and then
destroyed.
The results of the research may be published but your name and identity will not be
revealed. In order to maintain confidentiality of your records only aggregated data
will be used. Following the study, only the primary investigator will have access to
the original data. The original data will be retained in a locked cabinet for a minimum
of three years after the completion of the study in the department of Health, Physical
Education, and Recreation at Western Michigan University and then destroyed.
The conditions that must be met in order for you to participate in this study include an
injury-free right thigh for the previous one-month. You must be of ages 18-40. You
must not be involved in unaccustomed, physical activity for more than 10 hours per
week or involved in competitive sports. You must not be taking non-steroidal anti
inflammatory medications.
You may withdraw from this study at any time without prejudice, penalty, or risk of
loss of service you would otherwise receive. You will experience NO consequences
both academically or personally if you choose to withdraw from this study. Should
you have any questions prior to or during the study, you can contact the student
investigator, Michaelyn Sebold, at 269-353-9967, or the primary investigator, Dr.
Michael Miller at 269-387-2728. You may also contact the Chair, Human Subjects
Institutional Review Board at 269-387-8293 or the Vice President for Research at
269-387-8298 if questions arise during the course of the study.
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Appendix C
Visual Analog Scale
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VAS Scales (Hours 8, 12, 24, 36, 72)
Please Indicate Your Subject ID Number:
Please Indicate the Corresponding Hour:

(Only indicate one of the five hour choices listed---8, 12, 24, 36, 72)

Perceived Soreness Rating
Please circle the number that best corresponds to the level of pain you are experiencing at the time of
measurement. Consider alJ options! You may choose any number that corresponds to your experience.
The key below is just to help you understand what the numbers represent.

0

1

2

3

4

5

6

0 = No Soreness
2 = Minimal Soreness
4 = Mild Soreness
6 = Moderate Soreness
8 = Severe Soreness
10 = Extreme or Unbearable Soreness
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7

8

9

10

Appendix D
Par-Q Questionnaire
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Par-Q Questionnaire
Please read the questions carefully and answer each one honestly. Check YES or NO.
YES

□

NO

□

1. Has your doctor ever said that you have a heart
condition and that you should only do physical activity
recommended by a doctor?

□

□

2. Do you feel pain in your chest when you do physical
activity?

□

□

3. In the past month, have you had chest pain when you
were not doing physical activity?

□

□

4. Do you lose your balance because of dizziness or do you
ever lose consciousness?

□

□

5. Do you have a bone or joint problem that could be made
worse by a change in your physical activity?

□

□

6. Is your doctor currently prescribing drugs for your blood
pressure or heart condition?

□

□

7. Do you know of any other reason you should not do
physical activity?

I have read, understood, and completed this questionnaire. Any questions I had were
answered to my full satisfaction.
Name---------------- Date---------Signature_______________Witness________
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